Search by Drug Name or NDC
NDC 63323-0064-02 Magnesium Sulfate 500 mg/mL Details
Magnesium Sulfate 500 mg/mL
Magnesium Sulfate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
NDC | 63323-0064 |
---|---|
Product ID | 63323-064_331fa756-1a83-4b07-a373-486fbd0ca27a |
Associated GPIs | 79400010402020 |
GCN Sequence Number | 001417 |
GCN Sequence Number Description | magnesium sulfate VIAL 500 MG/ML INJECTION |
HIC3 | C1H |
HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
GCN | 04163 |
HICL Sequence Number | 000610 |
HICL Sequence Number Description | MAGNESIUM SULFATE |
Brand/Generic | Generic |
Proprietary Name | Magnesium Sulfate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | MAGNESIUM SULFATE HEPTAHYDRATE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 500 |
Active Ingredient Units | mg/mL |
Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019316 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0064-02 (63323006402)
NDC Package Code | 63323-064-02 |
---|---|
Billing NDC | 63323006402 |
Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-064-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
Marketing Start Date | 2000-08-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |